Skip to main content
UTHR logo

United Therapeutics Corporation

UTHRNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$587.50Today:- (-)1Y +37.21%

As of Oct 23, 2026 close

Market cap
$26.91B
P/E (TTM)
20.53
Forward P/E
19.89
Dividend yield
-
52-week range
$409.07$609.35
Volume (live)
-
Avg. volume (3M)
913.17K

United Therapeutics Corporation (UTHR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for United Therapeutics Corporation stock.

Analyst Consensus Rating

Investment consensus from 17 professional research analysts

Consensus Rating

Buy
Based on 17 unique analysts
(30 total ratings in last 90 days)
High Confidence2.8:1 Buy/Sell

Average Price Target

$659.57
+12.27% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest UTHR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Lisa Walter
RBC Capital
BuyReiterates
$708.00 → $697.00
Tiago Fauth
Raymond James
BuyMaintains
$685.00 → $717.00
Roanna Ruiz
Leerink Partners
BuyReiterates
$685.00 → $725.00
Benjamin Burnett
Wells Fargo
BuyMaintains
$700.00
Andrea Newkirk
Goldman Sachs
SellMaintains
$321.00 → $368.00
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-
Ashwani Verma
UBS
BuyMaintains
$725.00
Ashwani Verma
UBS
BuyMaintains
$725.00
Roanna Ruiz
Leerink Partners
BuyReiterates
$685.00
Jason Gerberry
BofA Securities
HoldReiterates
$559.00
Jessica Fye
JP Morgan
BuyMaintains
$687.00 → $710.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Jessica Fye
JP Morgan
BuyMaintains
$687.00 → $710.00
Lisa Walter
RBC Capital
BuyMaintains
$677.00 → $708.00
Terence Flynn
Morgan Stanley
HoldMaintains
$566.00
Olivia Brayer
Cantor Fitzgerald
BuyInitiates
$700.00
Julian Harrison
BTIG
BuyUpgrades
$728.00
Roanna Ruiz
Leerink Partners
BuyReiterates
$685.00
Roger Song
Jefferies
BuyMaintains
$704.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Olivia Brayer
Cantor Fitzgerald
BuyInitiates
$700.00
Lisa Walter
RBC Capital
BuyReiterates
$677.00
Andrea Newkirk
Goldman Sachs
SellInitiates
$321.00
Andrea Newkirk
Goldman Sachs
SellInitiates
$321.00
Ekta Bagri
Zacks Equity Research
SellInitiates Coverage
-
Joseph Thome
TD Cowen
BuyMaintains
$675.00
Benjamin Burnett
Wells Fargo
BuyMaintains
$700.00
Kanishka Das
Zacks Equity Research
SellInitiates Coverage
-
Andrew Fein
HC Wainwright
BuyMaintains
$660.00
Terence Flynn
Morgan Stanley
HoldInitiates Coverage
$516.00 → $515.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for UTHR?

The analyst consensus rating for UTHR is Buy, based on the latest ratings from 17 analysts over the last 90 days.

What is the average price target for UTHR?

The average 12-month price target for UTHR is $659.57, representing an upside of 12.3% from the Oct 23, 2026 close of $587.50.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.